Abstract:Degeneration or loss of GABAergic neurons frequently may lead to many neuropsychiatric disorders such as epilepsy and autism spectrum disorders. So far no clinically effective therapies can slow and halt the progression of these diseases. Cell-replacement therapy is a promising strategy for treatment of these neuropsychiatric diseases. Although increasing evidence showed that mammalian somatic cells can be directly converted into functional neurons using specific transcription factors or miRNAs via virus delivery, the application of these induced neurons is potentially problematic, due to integration of vectors into the host genome, which results in the disruption or dysfunction of nearby genes. Here, we show that mouse fibroblasts could be efficiently reprogrammed into GABAergic neurons in a combined medium composed of conditioned medium from neurotrophin-3 modified Olfactory Ensheathing Cells (NT3-OECs) plus SB431542, GDNF and RA. Following 3weeks of induction, these cells derived from fibroblasts acquired the morphological and phenotypical GABAerigic neuronal properties, as demonstrated by the expression of neuronal markers including Tuj1, NeuN, Neurofilament-L, GABA, GABA receptors and GABA transporter 1. More importantly, these converted cells acquired neuronal functional properties such as synapse formation and increasing intracellular free calcium influx when treated with BayK, a specific activator of L-type calcium channel. Therefore, our findings demonstrate for the first time that fibroblasts can be directly converted into GABAergic neurons without ectopic expression of specific transcription factors or miRNA. This study may provide a promising cell source for the application of cell replacement therapy in neuropsychiatric disorders.

Plasmid-based generation of neural cells from human fibroblasts using non-integrating episomal vectors

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Neural Differentiation of Fibroblasts Induced by Intracellular Co-Delivery of Ascl1, Brn2 and FoxA1 Via a Non-Viral Vector of Cationic Polysaccharide

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Generation of Patient-Specific Induced Neuronal Cells Using A Direct Reprogramming Strategy

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Generation of induced neural stem/progenitor cells from human fibroblasts

Small Molecular Compounds Efficiently Convert Human Fibroblasts Directly into Neurons

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Generation of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts

Generation of Human Neurons by microRNA-Mediated Direct Conversion of Dermal Fibroblasts

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Generation of non-integrating induced pluripotent stem cells with episomal plasmids and differentiation into neural stem cells

Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons

Conversion of Human Fibroblasts into Induced Neural Stem Cells by Small Molecules

Neurogenin 2 Enhances the Generation of Patient-Specific Induced Neuronal Cells.

Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules

Direct Conversion of Mouse Fibroblasts to Gabaergic Neurons with Combined Medium Without the Introduction of Transcription Factors or Mirnas

Reprogramming Fibroblasts to Neural Stem Cells by Overexpression of the Transcription Factor Ptf1a